Publications by authors named "Peter Devilee"

Claim this Profile
L
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer.
Amandine Billaud, Gisella Figlioli, Clémence Mooser, Irene Casamassima, Violette Azzoni, Peter Devilee

Breast· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Kate Lawrenson, Siddhartha Kar, Karen McCue, Karoline Kuchenbaeker, Kyriaki Michailidou, Peter Devilee

Nat Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification.
Maria Zanti, Denise G O'Mahony, Michael T Parsons, Leila Dorling, Joe Dennis, Peter Devilee

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction.
Kristia Yiangou, Nasim Mavaddat, Joe Dennis, Maria Zanti, Qin Wang, Peter Devilee

Breast Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset.
Aimee L Davidson, Kyriaki Michailidou, Michael T Parsons, Cristina Fortuno, Manjeet K Bolla, Peter Devilee

Am J Hum Genet· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of more than 400,000 women provides case-control evidence for and variant classification.
Maria Zanti, Denise G O'Mahony, Michael T Parsons, Leila Dorling, Joe Dennis, Peter Devilee

medRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers.
Iris A S Stroot, Joost Bart, Harry Hollema, Mathilde Jalving, Marise M Wagner, Peter Devilee

Gynecol Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Understanding the genetic complexity of puberty timing across the allele frequency spectrum.
Katherine A Kentistou, Lena R Kaisinger, Stasa Stankovic, Marc Vaudel, Edson Mendes de Oliveira, Peter Devilee

Nat Genet· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the genetic complexity of puberty timing across the allele frequency spectrum.
Katherine A Kentistou, Lena R Kaisinger, Stasa Stankovic, Marc Vaudel, Edson Mendes de Oliveira, Peter Devilee

Nat Genet· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of incorporating genetic and non-genetic risk factors in CanRisk-based breast cancer risk prediction.
Anja Tüchler, Antoine De Pauw, Corinna Ernst, Amélie Anota, Inge M M Lakeman, Peter Devilee

Breast· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction.
Kristia Yiangou, Nasim Mavaddat, Joe Dennis, Maria Zanti, Qin Wang, Peter Devilee

medRxiv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Minigene-Based Splicing Analysis and Tentative Clinical Classification of 52 CHEK2 Splice-Site Variants.
Lara Sanoguera-Miralles, Alberto Valenzuela-Palomo, Elena Bueno-Martínez, Ada Esteban-Sánchez, Víctor Lorca, Peter Devilee

Clin Chem· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.
Hagai Levi, Shai Carmi, Saharon Rosset, Rinat Yerushalmi, Aviad Zick, Peter Devilee

J Med Genet· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.
Naomi Wilcox, Martine Dumont, Anna González-Neira, Sara Carvalho, Charles Joly Beauparlant, Peter Devilee

Nat Genet· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.
Naomi Wilcox, Martine Dumont, Anna González-Neira, Sara Carvalho, Charles Joly Beauparlant, Peter Devilee

Nat Genet· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-gene panel testing and association analysis in Cypriot breast cancer cases and controls.
Maria Zanti, Maria A Loizidou, Denise G O'Mahony, Leila Dorling, Joe Dennis, Peter Devilee

Front Genet· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
Anna Morra, Maartje A C Schreurs, Irene L Andrulis, Hoda Anton-Culver, Annelie Augustinsson, Peter Devilee

Cancer Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectrum and Frequency of Germline Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.
Gisella Figlioli, Amandine Billaud, Qin Wang, Manjeet K Bolla, Joe Dennis, Peter Devilee

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the genetic complexity of puberty timing across the allele frequency spectrum.
Katherine A Kentistou, Lena R Kaisinger, Stasa Stankovic, Marc Vaudel, Edson M de Oliveira, Peter Devilee

medRxiv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.
Gisella Figlioli, Amandine Billaud, Thomas U Ahearn, Natalia N Antonenkova, Heiko Becher, Peter Devilee

Eur J Hum Genet· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LncRNA LITATS1 suppresses TGF-β-induced EMT and cancer cell plasticity by potentiating TβRI degradation.
Chuannan Fan, Qian Wang, Thomas B Kuipers, Davy Cats, Prasanna Vasudevan Iyengar, Peter Devilee

EMBO J· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants.
Taru A Muranen, Anna Morra, Sofia Khan, Daniel R Barnes, Manjeet K Bolla, Peter Devilee

NPJ Breast Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of coding germline variants on contralateral breast cancer risk and survival.
Anna Morra, Nasim Mavaddat, Taru A Muranen, Thomas U Ahearn, Jamie Allen, Peter Devilee

Am J Hum Genet· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
Anna Morra, Maartje A C Schreurs, Irene L Andrulis, Hoda Anton-Culver, Annelie Augustinsson, Peter Devilee

Res Sq· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry.
Stefanie H Mueller, Alvina G Lai, Maria Valkovskaya, Kyriaki Michailidou, Manjeet K Bolla, Peter Devilee

Genome Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis